19 results
SC 13G/A
EX-1
Ayrton Capital LLC
16 Feb 21
SUNESIS PHARMACEUTICALS / Ayrton Capital ownership change
11:06am
8-K
EX-1.1
VIRX
Viracta Therapeutics Inc
31 Jul 20
Other Events
12:00am
SC 13G/A
EX-1
RTW Investments, LP
14 Feb 20
Beneficial ownership report (amended)
1:32pm
SC 13G
EX-1
RTW Investments, LP
22 Jul 19
Sunesis Pharmaceuticals Inc
9:23am
8-K
EX-1.1
VIRX
Viracta Therapeutics Inc
11 Jul 19
Material Modifications to Rights of Security Holders
8:12pm
8-K
EX-1.2
4gibm2jcpys
11 Jul 19
Material Modifications to Rights of Security Holders
8:12pm
8-K
EX-1.1
ve9tqd6t4mvy8o36c1
18 Jan 19
Material Modifications to Rights of Security Holders
8:35pm
8-K
EX-1.2
1lvav
18 Jan 19
Material Modifications to Rights of Security Holders
8:35pm
8-K
EX-1.1
ke8 wosm1cpr66qi4
26 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.2
67m3jpf
26 Oct 17
Entry into a Material Definitive Agreement
12:00am
SC 13G
EX-1
p8xq3
31 Oct 16
Sunesis Pharmaceuticals Inc
12:00am
8-K
EX-1.1
tg620 okqpn
19 Oct 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.2
2j0wd
19 Oct 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
ez75ele 0apio44w
16 Dec 15
Sunesis Announces Pricing of $25 Million Offering of Securities
12:00am
8-K
EX-1.2
64qvi
16 Dec 15
Sunesis Announces Pricing of $25 Million Offering of Securities
12:00am
8-K
EX-1.1
isx0c9g juedomq7v
27 Feb 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
lverceiw 7h9k58q
1 Oct 10
Sunesis Prices $15.5 Million Offering
12:00am
8-K
EX-1.1
mdu8tkqebubvxdw v22
24 May 07
Sunesis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
12:00am
- Prev
- 1
- Next